Skip to main navigation Skip to search Skip to main content

Clinical standards for the assessment, management and rehabilitation of post-TB lung disease

  • Giovanni Battista Migliori
  • , F. M. Marx
  • , N. Ambrosino
  • , E. Zampogna
  • , H. S. Schaaf
  • , M. M. van der Zalm
  • , B. Allwood
  • , A. L. Byrne
  • , Kevin Mortimer
  • , R. S. Wallis
  • , G. J. Fox
  • , C. C. Leung
  • , J. M. Chakaya
  • , B. Seaworth
  • , A. Rachow
  • , B. J. Marais
  • , J. Furin
  • , O. W. Akkerman
  • , F. Al Yaquobi
  • , A. F.S. Amaral
  • S. Borisov, J. A. Caminero, A. C.C. Carvalho, D. Chesov, L. R. Codecasa, R. C. Teixeira, M. P. Dalcolmo, Sumona Datta, A. T. Dinh-Xuan, R. Duarte, C. A. Evans, J. M. García-García, G. Günther, G. Hoddinott, S. Huddart, O. Ivanova, R. Laniado-Laborín, S. Manga, K. Manika, A. Mariandyshev, F. C.Q. Mello, S. G. Mpagama, M. Muñoz-Torrico, P. Nahid, C. W.M. Ong, D. J. Palmero, A. Piubello, E. Pontali, D. R. Silva, R. Singla, A. Spanevello, S. Tiberi, Z. F. Udwadia, M. Vitacca, R. Centis, L. D'Ambrosio, G. Sotgiu, C. Lange, D. Visca
  • IRCCS Istituti Clinici Scientifici Maugeri S.p.A. SB - Pavia
  • Stellenbosch University
  • University of New South Wales
  • Partners in Health
  • Aurum Institute for Health Research
  • University of Sydney
  • Chest and Heart Diseases Association
  • Kenyatta University
  • Liverpool School of Tropical Medicine
  • Heartland National TB Center
  • University of Texas Health Center at Tyler
  • Ludwig Maximilian University of Munich
  • Partner Site Munich
  • Harvard University
  • University of Groningen
  • Ministry of Health, Oman
  • Imperial College London
  • Moscow Healthcare Department
  • University General Hospital of Gran Canaria ''Dr Negrin''
  • ALOSA TB ACADEMY
  • Fundação Oswaldo Cruz
  • State University of Medicine and Pharmacy "Nicolae Testemiţanu"
  • Research Center Borstel - Leibniz Lung Center
  • Asst Grande Ospedale Metropolitano Niguarda
  • National Institute of Respiratory Diseases and the Environment (INERAM)
  • Radboud University Nijmegen
  • Universidad Peruana Cayetano Heredia
  • Asociación Benéfica Prisma
  • Université Paris Cité
  • University of Porto
  • Tuberculosis Research Programme SEPAR
  • University of Bern
  • University of California at San Francisco
  • San Francisco Department of Public Health
  • Universidad Autonoma de Baja California
  • Medecins Sans Frontieres
  • Aristotle University of Thessaloniki
  • Northern State Medical Academy
  • Universidade Federal do Rio de Janeiro
  • Kilimanjaro Christian Medical College
  • Instituto Nacional de Enfermedades Respiratorias
  • National University of Singapore
  • Hospital de Infecciosas Francisco Javier Muñiz
  • Damien Foundation
  • Galliera Hospital
  • Universidade Federal do Rio Grande do Sul
  • National Institute of Tuberculosis & Respiratory Diseases
  • University of Insubria
  • Barts Health NHS Trust
  • Queen Mary University of London
  • P.D. Hinduja National Hospital and Medical Research Centre
  • Public Health Consulting Group SAGL
  • University of Sassari
  • German Center for Infection Research, Borstel Partner Site
  • University of Lübeck

Research output: Contribution to journalArticlepeer-review

170 Citations (Scopus)

Abstract

BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR).
METHODS: A panel of global experts in the field of TB care and PR was identified; 62 participated in a Delphi process. A 5-point Likert scale was used to score the initial ideas for standards and after several rounds of revision the document was approved (with 100% agreement).
RESULTS: Five clinical standards were defined: Standard 1, to assess patients at the end of TB treatment for PTLD (with adaptation for children and specific settings/situations); Standard 2, to identify patients with PTLD for PR; Standard 3, tailoring the PR programme to patient needs and the local setting; Standard 4, to evaluate the effectiveness of PR; and Standard 5, to conduct education and counselling. Standard 6 addresses public health aspects of PTLD and outcomes due to PR.
CONCLUSION: This is the first consensus-based set of Clinical Standards for PTLD. Our aim is to improve patient care and quality of life by guiding clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage PTLD.
Original languageEnglish
Pages (from-to)797-813
Number of pages17
JournalInternational Journal of Tuberculosis and Lung Disease
Volume25
Issue number10
DOIs
Publication statusPublished - 1 Oct 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Clinical standards
  • Post-TB lung disease
  • Pulmonary rehabilitation
  • Sequelae
  • Tuberculosis

Fingerprint

Dive into the research topics of 'Clinical standards for the assessment, management and rehabilitation of post-TB lung disease'. Together they form a unique fingerprint.

Cite this